abstract |
Formula I:n n n [Formula I]n n n n n n n n (In formula,n n n X represents a linking group having 2 to 5 atoms in the main chain (the linking group may have a substituent),n n n A represents a hydrogen atom or an acetyl group,n n n E represents an aryl group which may have a substituent or a heteroaryl group which may have a substituent,n n n Ring Z is an arene which may further have a substituent in addition to the group represented by the formula -OA (wherein A is the same as defined above) and formula -XE (wherein X and E are the same as defined above); Or heteroarene which may further have a substituent in addition to the group represented by the formula -OA (wherein A is the same as defined above) and formula -XE (wherein X and E are the same as defined above). Prevention of allergic diseases and / or endometriosis and / or uterine fibroids, comprising as an active ingredient a compound selected from the group consisting of a compound and a pharmacologically acceptable salt thereof, their hydrates and their solvates thereof. And / or medication for treatment. |